Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
183 participants
OBSERVATIONAL
2015-02-28
2017-03-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Preoperative Evaluation of the Remaining Part of the Liver for Liver Resection
NCT04100304
Risk Factors for Major Complications After Liver Resection
NCT03967067
Recurrence of Liver Malignancy After Ischemia/Reperfusion Injury
NCT04257240
Novel Preoperative Score Predicting Outcome Following Liver Resection
NCT01003197
Quality of Life After Liver Resection
NCT00681499
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
RETROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Patients submitted to liver resection
Patients underwent liver resection for primary and secondary disease
Liver resection for primary and secondary disease
Liver resection in parenchyma-sparing setting for primary and secondary disease
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Liver resection for primary and secondary disease
Liver resection in parenchyma-sparing setting for primary and secondary disease
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
18 Years
80 Years
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
University of Milan
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Prof. Guido Torzilli
MD, PhD, FACS
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Guido Torzilli, MD, PhD
Role: PRINCIPAL_INVESTIGATOR
Humanitas University
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
CE Humanitas 100/15
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.